Biotech

All Articles

Capricor shares more information for DMD treatment after starting BLA

.Capricor Rehabs is actually taking a victory lap for their phase 2 Duchenne muscle dystrophy (DMD) ...

FDA spots Kezar lupus trial in grip complying with 4 individual fatalities

.The FDA has positioned Kezar Lifestyle Sciences' lupus trial on grip after the biotech hailed four ...

Phase 3 Scholar Rock trial hits SMA objective, sending out stock up 200%

.A period 3 test of Historian Stone's spinal muscular degeneration (SMA) candidate has actually reac...

CAMP 4 is most current to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Therapies has actually defined think about a $67 million IPO, with inflammation-f...

Galecto acquires leukemia medicine, drops bone cancer cells resource in pivot

.A year after the failing of an idiopathic lung fibrosis prospect sent out Galecto on a search for s...

Judo tosses down $100M to knock out renal ailment

.Taking the floor covering is Judo Biography, a promising biotech equipped along with $100 million t...

AstraZeneca pays CSPC $100M for preclinical cardiovascular disease medicine

.AstraZeneca has actually settled CSPC Pharmaceutical Team $100 million for a preclinical cardiovasc...

Zephyrm seeks Hong Kong IPO to money stage 3 tissue therapy trials

.Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankr...

Frazier Life Sciences gets $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced a further $630 million for its fund focused on littl...

GigaGen amasses around $135M BARDA dollars to hammer botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own technic...